RENAL TRANSPLANTATION
Clinical trials for RENAL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new RENAL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for RENAL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant breakthrough: Biopsy-Guided drug plan may cut rejection and side effects
Disease control CompletedThis study looked at 346 kidney transplant patients to see if a biopsy taken 3 months after surgery could help doctors better manage anti-rejection drugs. Patients with mild signs of rejection were given extra treatment, while those with no inflammation had their steroids reduced…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 17, 2026 05:22 UTC
-
Kidney transplant breakthrough: could this be the end of lifelong pills?
Disease control CompletedThis early-stage study tested a new approach to help kidney transplant recipients stop taking anti-rejection drugs. Eight adults received donor stem cells along with a special drug combination, aiming to train their immune system to accept the new kidney without long-term medicat…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
Shake or sweat: which exercise helps kidney transplant patients more?
Disease control CompletedThis study looked at two types of exercise—whole body vibration and aerobic training—in 60 adults who had a kidney transplant. The goal was to see which one better reduced inflammation (measured by interleukin-6) and improved endurance. Participants did their assigned exercise fo…
Matched conditions: RENAL TRANSPLANTATION
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Kidney transplant study: can hemoglobin goals slow organ decline?
Disease control CompletedThis study tested whether keeping hemoglobin at different levels improves quality of life and slows kidney damage in people who have had a kidney transplant and now have chronic graft dysfunction. About 128 adults who received a transplant 1 to 20 years ago and have reduced kidne…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo aims to make kidney transplants safer and Longer-Lasting
Disease control CompletedThis study tested a new combination of drugs (siplizumab and belatacept) against standard care in 76 people who just received a kidney transplant. The goal was to see if the new combo is safer and helps the kidney work better. Participants took these medications for life to preve…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Vitamin d study aims to boost bone health in kids with kidney disease
Disease control CompletedThis study looked at whether the standard vitamin D supplement (cholecalciferol) helps children with chronic kidney disease, kidney transplants, or nephrotic syndrome reach healthy vitamin D levels. 43 children took a single high-dose vitamin D vial, and researchers measured thei…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Scientists test fluid to predict kidney transplant outcomes
Knowledge-focused CompletedThis study looked at whether testing the fluid used to preserve donor kidneys on a special machine could help doctors know how well the kidney will work after transplant. Researchers measured certain chemicals in the fluid and compared them to how the kidney functioned in the fir…
Matched conditions: RENAL TRANSPLANTATION
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated May 17, 2026 05:06 UTC
-
Kidney transplant drug dosing under the microscope
Knowledge-focused CompletedThis study involved 45 kidney transplant patients and aimed to learn more about how the drug Advagraf (a type of tacrolimus) is processed by the body after transplantation. Researchers measured drug levels in the blood to find better ways to determine the right dose. No new treat…
Matched conditions: RENAL TRANSPLANTATION
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC